Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ZBH Zimmer Biomet Holdings Inc

Price (delayed)

$96.95

Market cap

$19.18B

P/E Ratio

21.4

Dividend/share

$0.96

EPS

$4.53

Enterprise value

$24.97B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
ZBH's quick ratio has soared by 92% YoY and by 55% QoQ
ZBH's P/E is 75% lower than its 5-year quarterly average of 84.6 and 7% lower than its last 4 quarters average of 22.9
The debt has increased by 24% year-on-year and by 16% since the previous quarter
The net income has declined by 5% year-on-year

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
197.85M
Market cap
$19.18B
Enterprise value
$24.97B
Valuations
Price to earnings (P/E)
21.4
Price to book (P/B)
1.56
Price to sales (P/S)
2.5
EV/EBIT
19.47
EV/EBITDA
10.88
EV/Sales
3.24
Earnings
Revenue
$7.7B
Gross profit
$5.47B
Operating income
$1.31B
Net income
$913.4M
EBIT
$1.28B
EBITDA
$2.29B
Free cash flow
-$244M
Per share
EPS
$4.53
EPS diluted
$4.51
Free cash flow per share
-$1.23
Book value per share
$62.27
Revenue per share
$38.71
TBVPS
$43.88
Balance sheet
Total assets
$22.18B
Total liabilities
$9.78B
Debt
$7.18B
Equity
$12.4B
Working capital
$3.3B
Liquidity
Debt to equity
0.58
Current ratio
2.44
Quick ratio
1.27
Net debt/EBITDA
2.52
Margins
EBITDA margin
29.8%
Gross margin
71.1%
Net margin
11.9%
Operating margin
17%
Efficiency
Return on assets
4.2%
Return on equity
7.3%
Return on invested capital
11.8%
Return on capital employed
6.4%
Return on sales
16.7%
Dividend
Dividend yield
0.99%
DPS
$0.96
Payout ratio
21.2%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
0.23%
1 week
1.83%
1 month
0.01%
1 year
-20.03%
YTD
-8.22%
QTD
-14.34%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.7B
Gross profit
$5.47B
Operating income
$1.31B
Net income
$913.4M
Gross margin
71.1%
Net margin
11.9%
The net margin has declined by 8% year-on-year
Zimmer Biomet Holdings's operating income has increased by 8% YoY and by 2% QoQ
The net income has declined by 5% year-on-year
Zimmer Biomet Holdings's operating margin has increased by 4.3% YoY

Price vs fundamentals

How does ZBH's price correlate with its fundamentals

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
21.4
P/B
1.56
P/S
2.5
EV/EBIT
19.47
EV/EBITDA
10.88
EV/Sales
3.24
ZBH's P/E is 75% lower than its 5-year quarterly average of 84.6 and 7% lower than its last 4 quarters average of 22.9
The EPS has contracted by 2.4% YoY
The stock's P/B is 26% below its 5-year quarterly average of 2.1 and 13% below its last 4 quarters average of 1.8
ZBH's price to sales (P/S) is 34% lower than its 5-year quarterly average of 3.8 and 14% lower than its last 4 quarters average of 2.9
The revenue has grown by 3.3% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROA has contracted by 7% YoY
Zimmer Biomet Holdings's return on equity has decreased by 5% YoY
The ROIC has increased by 4.4% YoY
The ROS has grown by 3.7% YoY and by 2.5% from the previous quarter

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.99%
Payout ratio
21.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 127% higher than the total liabilities
ZBH's quick ratio has soared by 92% YoY and by 55% QoQ
The current ratio has grown by 47% YoY and by 28% from the previous quarter
The debt is 42% smaller than the equity
The debt to equity has grown by 26% year-on-year and by 16% since the previous quarter
The debt has increased by 24% year-on-year and by 16% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.